Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders

Abstract

Parkinson’s disease is a neurological disorder that affects both motor and non-motor functions, including depression, anxiety, and cognitive decline. Currently, it remains a challenge to distinguish the correlation between these aspects and their impact on one another. To try to clarify these reciprocal influences, in this study we have used specific radio electric asymmetric conveyer (REAC) technology neuromodulation treatments for behavioral mood disorders and adjustment disorders. In particular, we employed the neuro-postural optimization (NPO) and neuro-psycho-physical optimization (NPPOs) treatments. The study enrolled randomly 50 subjects of both genders previously diagnosed with Parkinson’s disease for at least six months. Prior to and following REAC NPO and NPPOs treatments, we assessed the subjects using functional dysmetria (FD) evaluation, five times sit to stand test (FTSST) for postural stability, and the 12-item Short-Form Health Survey (SF-12) for quality of life (QLF) evaluation. The positive results produced by the REAC NPO and NPPOs neuromodulation treatments, specific for mood and adaptation disorders, on dysfunctional motor disorders, and quality of life confirm how the non-motor components can condition the symptomatology of Parkinsonian motor symptoms. These results also highlight the usefulness of REAC NPO and NPPOs treatments in improving the overall quality of life of these patients.

Improving Strength and Fatigue Resistance in Post-Polio Syndrome Individuals with REAC Neurobiological Treatments

“…It was expected that these treatments would produce more noticeable results on the RPFS, but statistically significant improvements were observed mainly in motor aspects, as demonstrated above. These findings suggest that, despite the administration of treatments with NPPOs, known for their broad and demonstrated efficacy, improvement in several mood and behavioral disorders [28,29,32] that influence the clinical and symptomatic progression of patients with PPS may not be immediately noticed. Unconsciously, this improvement may initially result in emotional instability, possibly due to the disruption of long-standing dysfunctional neuro psycho adaptive patterns.…”

“…Treatments targeting NPPOs have been administered to treat mood and behavioral disorders [28,29]. It was expected that these treatments would produce more noticeable results on the RPFS.…”

“…This includes promoting the restoration of disrupted neural processes, facilitating neuroplasticity, and optimizing neuronal communication. These mechanisms contribute to the overall improvement of neurological functions, leading to enhanced recovery and well-being [28,29].…”

“…The specific REAC treatments employed in this study NPPO and NPPO-CB represent an advanced neuromodulation treatment that focuses on optimizing human performance by acknowledging the intricate relationship between the nervous system, psychological well-being, and physical body [29].…”